Global pharma major Lupin Limited (Lupin) announced that it has launched rivaroxaban tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application from the US FDA.

The shares of Indian pharmaceutical company Lupin rose 2.6% to their day’s high of Rs 2,081.95 on the BSE on Monday, March 10, after the company launched its Rivaroxaban Tablets USP, 2.5mg in ...